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‘Writing a book is a horrible, exhausting struggle, like a long bout of some painful illness.’ 
So wrote George Orwell in 1946. I wholeheartedly concur but would substitute ‘thesis’ 
for ‘book’. This struggle, however, was made bearable by the collective contributions of 
so many that it may be difficult to enumerate. 
First, my thanks to my promoters Pieter de Graeff and Hans Hillege for supporting my 
secondment to the European Medicines Agency to participate in the EMA Benefit Risk 
(BR) Methodology Project. They provided the freedom for me to pursue the direction 
I wished to take for the thesis  and for that they have my unending gratitude. The 
objectives of the project and the opportunity for seeing first-hand how medicines are 
regulated in Europe provided an invaluable learning experience. Next, my thanks go 
to Hans-Georg Eichler, who in his role as Senior Medical Officer of the EMA took a 
great deal of interest in the development of my thesis and provided a sounding board 
for my ideas and frustrations and giving valuable advice. I also owe him a huge debt of 
gratitude for suggesting that I pursue the development of a model that would support 
the representative interaction of patients in the regulatory process, and it is worth saying 
that without his encouragement my thesis would not have taken this particular direction.
Then there is Professor Larry Phillips of the London School of Economics and Political 
Science (LSE). I owe so much to Larry. As leader of the EMA BR Methodology Project, 
he set the standard of academic achievement that was expected from anyone purporting 
to participate in the project and always pushed me to go further and dig deeper. He 
has worked with many of the giants in the field of behavioural psychology, behavioural 
economics and decision theory, and each conversation with him was an education in itself. 
My determination to prove myself and my scholarship worthy in his eyes was a major 
driving force in the completion of this thesis. Many thanks also go to Professor Barbara 
Fasolo, also from the LSE, who was the first to read my proposals on risk perception among 
the assessors and say ‘you are going in a good direction’. Her calm manner and positive 
outlook coupled with her deep knowledge of the field of risk research were invaluable 
during the years in which we worked together on the EMA BR Methodology Project.  
I can truly say that it has been a pleasure to work with Professor Carlos Bana e Costa. 
During the writing of a paper we co-authored, he once said ‘At the end of this you 
will either love me or hate me’. Needless to say, I do not hate Carlos; he is a scholar 
extraordinaire and has spent countless hours explaining the intricacies of the MACBETH 
approach and supporting the development of the VALUE study questionnaire to capture 
patient preferences. Together, he and Joao Bana e Costa have put in countless hours to 
support the programming required to create a user interface linked to the MACBETH 
software, with Joao sometimes sleeping only a few hours a day to meet the timelines. 






A special thought for my family and friends, named and unnamed, who suffered my 
physical absence at family gatherings and weekends while I completed this thesis. 
To friends who read endless drafts and rewrites and provided helpful comments to 
improve the clarity of my writing, my deep and sincere gratitude. Big thanks to Ettore 
and his parents Bruna and Giuseppe Brambilla; you provided me with the love and 
encouragement I needed each time I came home to Italy weary from travel and the 
demands of juggling life and work in London. To my mother and my belated father, Vera 
and Raymond Phillips, you have both, in different ways, inspired me to excel at whatever 
task I undertake; thank you for laying that foundation early in my life. Thanks to Enrica 
Alteri who, as a friend for many years and more recently a colleague at the EMA, has 
been support personified, always ready with a quick hug and an encouraging word. 
Thanks to Marisa Bacchi, my friend and previous supervisor, who always supported my 
aspirations and was my big champion when I decided to leave my job and embark on 
an academic career and who always let me know that there was a place for me whenever 
I wished to return. Thanks for that safety net. There were many times during the years 
when my hands hovered over the phone, but I resisted, as I knew you would be there 
whenever I was ready.
To Xavier Kurz, the EMA Lead for the IMI-PROTECT project who after observing my 
research progress at EMA exhibited his confidence in me by supporting the application of 
a grant to lead a study under the IMI-PROTECT WP6. The combination of the final year 
of my thesis coupled with the launch if the VISUALizE study was a perfect example of 
work-life imbalance and I would discourage anyone attempting to repeat the experience. 
However, by surviving this period, my confidence in my ability to make meaningful 
contributions to my chosen area of research increased tenfold. Support at this level is 
usually reserved for full professors, and I am humbled that Xavier sufficiently valued my 
work to support the ascension of UMCG to the IMI-PROTECT project. The study has been 
a success and I anticipate that we have enough data for at least eight or ten publications.
My thanks to the medical assessors in the participating National Competent Agencies 
who persevered through the completion of a 45-page questionnaire. This thesis would 
really not have been possible if they had not taken the hours and days needed to provide 
the data. It has been years now since the first questionnaire was launched, so the huge 
block of chocolate that each assessor received has probably faded in their memory, and so I 
reiterate my thanks here. Lastly, to the UK Multiple Sclerosis Society and the patients who 
participated in the VALUE study, you were the first to provide data for this application of 
the redesigned M-MACBETH. Thank you, not only for contributing to this current work 
but also for the continued struggle both at the organizational level and at the individual 






seems, with the advent of the recent IMI call for a project on how to involve patients in 
regulatory decision making, that the powers to be have heard you and the momentum is 
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Andrea was born in St Thomas, Jamaica and immigrated to New York with her parents 
and siblings in 1983. She graduated Magna Cum Laude from Spelman College in Atlanta, 
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worked on the studies presented in this thesis as a PhD student in the Department of 
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Prof. H. Hillege. In parallel she was a Visiting Research Student at the London School of 
Economics and Political Science where she worked closely with Prof. B. Fasolo. In January 
2013 she was successful in securing the ascension of the UMCG to the IMI-PROTECT 
project and has provided leadership for the IMI-PROTECT WP6 study Visualising 
Uncertainty Among Laypersons and Experts (VISUALizE), designed to collect data 
across three European countries on extending benefit-risk methodologies to patients, 
healthcare professionals and European medical assessors. 
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